An interventional study of Brief psychological intervention including attention training in Functional Cognitive Disorder, sponsored by King's College Hospital NHS Trust. Recruiting at 1 site in United Kingdom. Open to participants aged 18 Years to 65 Years. Per ClinicalTrials.gov, last updated 2026-01-30.
Sponsored by King's College Hospital NHS Trust · Not applicable, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 138 studies in Cognitive Dysfunction with a site in United Kingdom — 37 open to participants now, 54 under way, 7 of them phase 3. Cognitive Dysfunction · United Kingdom.
Among the 138 studies in Cognitive Dysfunction with a site in United Kingdom, this one is the 69th largest by planned enrollment of the 89 interventional ones that give a count, is one of 17 that started in 2025, is one of 51 with no phase, reaches primary completion later than 17 of the 53 other live ones, and was the 131st registered.
3,885 studies on the registry are indexed under Cognitive Dysfunction; 1,123 are open to participants now.
Browse Cognitive Dysfunction studies →37 of the 138 studies in Cognitive Dysfunction with a site in United Kingdom are open now. Recruiting first, the newest first:
University College, London · Sites in United Kingdom
Ages 55+
University of Edinburgh · Sites in United Kingdom
Ages 18+
University of Ulster · Sites in United Kingdom
Ages 50+ · Healthy volunteers
Prima Mente · Sites in United Kingdom
Ages 50+
University of Cambridge · Sites in United Kingdom
Ages 55+ · Healthy volunteers
A study can be open while its sites in United Kingdom have not opened yet or have stopped. Only those recruiting at a site in United Kingdom →
Of the 751 Cognitive Dysfunction studies recruiting now, 361 (48%) set no upper age limit and 144 (19%) stop at 75 or younger; 46 take children under 18; 260 take healthy volunteers.
This study: 18 Years to 65 Years · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
138 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 1 9 · Phase 2 17 · Phase 3 14 · Phase 4 1
First in 2004; this study’s year is marked. 17 started in 2025.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 30 is below the median of 64 across 2,804 interventional studies indexed under Cognitive Dysfunction.
Median enrollment 70 across the 89 interventional studies, 100 across the 49 observational. Of the 71 that completed or were terminated, 21 (30%) have results posted.
This tab as a report to print or save as PDF → With an account.
44 of 138 have an industry lead sponsor. The 10 most frequent:
King's College Hospital NHS Trust is the lead sponsor of 171 studies on the registry; 56 are open to participants now.
King's College Hospital NHS Trust has 2 studies filed under Cognitive Dysfunction — fewer than ten, so there is no comparison to draw.
8 of the studies in Cognitive Dysfunction with a site in United Kingdom that are under way reach primary completion within a year, 1 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT03887455Phase 3Eisai Inc.A Study to Confirm Safety and Efficacy of Lecanemab in Participants With Early Alzheimer's Disease | 2026-12-31 |
| NCT06207942Region SkaneStepcare Extended Follow-up Substudy | 2027-01 |
| NCT03507257Indiana UniversityLongitudinal Early-onset Alzheimer's Disease Study Protocol | 2027-01-01 |
| NCT06604104University of EdinburghVisual Frailty in Ageing | 2027-01-11 |
| NCT07466446University of EdinburghPost Intensive Care Accelerometery to Study and Support Recovery Outcomes | 2027-02-01 |
Add all 8 to your calendar (.ics) → With an account.
Among the 138 studies in Cognitive Dysfunction with a site in United Kingdom, from their registry updates:
This tab as a report to print or save as PDF → With an account.
The goal of this study is to learn if a single session intervention for people with Functional Cognitive Disorder (FCD) is feasible and acceptable. The main questions it aims to answer are:
What is the impact of a single session intervention on FCD symptoms, functional impairment, and quality of life in people with FCD?
What is the feasibility and acceptability of piloting a single session intervention for people with FCD.
Participants will:
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Behavioral: Brief psychological intervention including attention training
Brief psychological intervention including attention training
Participant recruitment, feasibility and retention from baseline to follow-up
• Number of participants recruited and retention rate (number and percentage of participants completing post-intervention measures) will be recorded.
Time frame: From enrollment to follow-up 6 weeks post-intervention.
Acceptability of the study intervention at follow-up
• At follow-up, participants will complete a questionnaire to collect information on acceptability of the study and intervention (Theoretical framework of acceptability \[TFA\] questionnaire; Sekhon et al., 2022).
Time frame: Post-intervention follow-up at 6 weeks.
Change in symptoms of depression from enrolment to post-intervention follow-up
Participants will complete questionnaire at enrolment and at follow-up post-intervention: • Patient Health Questionnaire 9 (PHQ-9) (Kroenke et al., 2001)
Time frame: At enrolment and at follow-up 6 weeks post-intervention
Change in symptoms of anxiety from enrolment to post-intervention follow-up
Participants will complete questionnaire at enrolment and at follow-up post-intervention: • Generalised Anxiety Disorder 7 questionnaire (GAD- 7) (Spitzer et al., 2006)
Time frame: At enrolment and at follow-up 6 weeks post-intervention
Change in functional impairment from enrolment to post-intervention follow-up
Participants will complete questionnaire at enrolment and at follow-up post-intervention: • Work and Social Adjustment Scale (WSAS) (Mundt et al., 2002)
Time frame: At enrolment and at follow-up 6 weeks post-intervention
Change in quality of life from enrolment to post-intervention follow-up
Participants will complete questionnaire at enrolment and at follow-up post-intervention: • EuroQol 5-Dimension 5-Level (EQ-5D-5L)(Herdman et al., 2011)
Time frame: At enrolment and at follow-up 6 weeks post-intervention
Change in self-reported cognitive symptoms from enrolment to post-intervention follow-up
Participants will complete questionnaire at enrolment and at follow-up post-intervention: • The Cognitive Failures Questionnaire 2.0(Goodhew \& Edwards, 2024).
Time frame: At enrolment and at follow-up 6 weeks post-intervention
Plan to share: No
No publications or documents are linked to this record.
Started Nov 2025 (actual). Primary completion is estimated for Mar 2026, 4 months after the start.
Of 1,453 non-industry interventional studies with no phase under Cognitive Dysfunction, half reached primary completion within 27 months of starting (the median), counting those still running; a quarter within 13 and three quarters within 51. This study's planned 4 months is below that.
Counting every sponsor, half of 1,522 studies reached it within 27 months; a quarter within 12 and three quarters within 50.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
No contact was published for this record. The registry link below has the sponsor’s details.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
King's College Hospital NHS Trust →